| MGB | Microbiota–gut–brain |
| SCFAs | Short-chain fatty acids |
| BDNF | Brain-derived neurotrophic factor |
| GF | Germ-Free |
| MDD | Major depressive disorder |
| AHN | Adult hippocampal neurogenesis |
| DG | Dentate gyrus |
| HPA | Hypothalamic–pituitary–adrenal |
| mPFC | Medial prefrontal cortex |
| GABA | Gamma-aminobutyric acid |
| fMRI | Functional magnetic resonance imaging |
| 5-HT | Serotonin |
| DA | Dopamine |
| NE | Norepinephrine |
| ENS | Enteric nervous system |
| MRIs | Structural magnetic resonance imaging |
| DTI | Diffusion tensor imaging |
| EEG | Electroencephalogram |
| BBB | Blood–brain barrier |
| ASD | Autism spectrum disorders |
| ADHD | Attention deficit hyperactivity disorder |
| EECs | Enteroendocrine cells |
| PAMPs | Pathogen-associated molecular patterns |
| CNS | Central nervous system |
| NTS | Nucleus of the solitary tract |
| DMV | Dorsal motor nucleus of the vagus nerve |
| TNF | Tumor necrosis factor |
| LPS | Lipopolysaccharide |
| TLRs | Toll-like receptors |
| IL-1β | Interleukin-1 beta |
| IL-6 | Interleukin-6 |
| TNF-α | Tumor Necrosis Factor-alpha |
| IFN-γ | Interferon-gamma |
| PYY | Peptide YY |
| GLP-1 | Glucagon-like peptide-1 |
| NPCs | Neural progenitor cells |
| HDACs | Histone deacetylases |
| LTP/LTD | Long-term potentiation/Long-term depression |
| PSD-95 | Postsynaptic density protein 95 |
| NGF | Nerve growth factor |
| GLIN | Glial cell lineage-derived neurotrophic factor |
| JAK/STAT | Janus Kinase/Signal Transducer and Activator of Transcription |
| NMDA | N-Methyl-D-Aspartate |
| CUMS | Chronic unpredictable mild stress |
| NMDAR2B | N–methyl–D–aspartate Receptor 2B |
| NMDAR1 | N–methyl–D–aspartate Receptor 1 |
| NMDA2A | N–methyl–D–aspartate Receptor 2A |
| mRNA | messenger RNA |
| GAD | Glutamate decarboxylase |
| 5-HT1A | 5-Hydroxytryptamine 1A receptor |
| DRD1 | Dopamine receptor D1 |
| ADRA-2A | Alpha-2A adrenergic receptor |
| NR3C2 | Mineralocorticoid receptor |
| CNR1 | Cannabinoid receptor type 1 |
| Adrb3 | β3-adrenergic receptor |
| Avpr1a | Vasopressin 1a receptor |
| Drd5 | Dopamine Receptor D5 |
| Htr2b | 5-hydroxytryptamine receptor 2B |
| SERT | 5-HT transporter |
| SSRIs | Selective serotonin reuptake inhibitors |
| THP-1 | Human monocytic leukemia cell line |
| IBS | Irritable bowel syndrome |
| miRNAs | microRNAs |
| NPY | Neuropeptide Y |
| RCTs | Randomized controlled trials |
| CSF | Cerebrospinal fluid |
| n-3 PUFA | Omega-3 polyunsaturated fatty acids |
| EPA | Eicosapentaenoic acid |
| DHA | Docosahexaenoic acid |
| VEGF-A | Vascular endothelial growth factor-A |
| DCX | Doublecortin |
| GABAA/B | Gamma-aminobutyric acid receptor types A and B |
| PI3K/Akt | Phosphoinositide 3-kinase/protein kinase B |
| RCT | Randomized controlled trial |
| OB | Oral probiotic |
| iPSC | Induced pluripotent stem cells |
| FMT | Fecal microbiota transplantation |